Stock Comparison
ABT vs SYK
Abbott Laboratories and Stryker Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$128.32B
P/E (TTM)
35.7
34.6
Forward P/E
20.0
22.3
Price/Sales
4.1
5.0
Price/Book
3.7
5.4
EV/EBITDA
18.6
20.1
Dividend Yield
1.66%
0.76%
Profitability
Net Margin
13.91%
13.21%
Operating Margin
18.17%
21.34%
Return on Equity
10.60%
16.50%
Return on Assets
5.33%
8.16%
Growth (YoY)
Revenue Growth
13.00%
9.40%
Earnings Growth
-47.50%
44.10%
Price & Risk
Beta
0.6
0.8
52-Week High
$134.48
$391.42
52-Week Low
$82.56
$282.58
Analyst Target
$118.42
$382.04
Compare ABT and SYK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.